Avsnitt
-
In this episode of DeviceTalks Weekly, Host Tom Salemi explores the breakthrough technologies—and the unique culture—driving one of MedTech's most ambitious missions with XCATH CEO Eduardo Fonseca. Fonseca shares the remarkable story behind XCATH's first remote robotic stroke procedure. Fonseca recounts the years of preparation, the high-stakes operation, and the emotional moment when a patient facing severe disability walked away with what he calls "a second birthday."
Along the way, Tom and Eduardo discuss AI's growing role in surgery, the global shortage of stroke specialists, the future of robotic intervention, and why expanding access—not simply advancing technology—is the company's ultimate goal.
To learn more about XCATH and talk with Fonseca, join us on July 29 for a live DeviceTalks discussion. Register here for the free webinar. Thank you to our sponsors Confluent, Jabil, Maxon, Solesis, Viant, and VitalPath.MassDevice Editor Chris Newmarker returns to deliver this episode’s Newmarker’s Newsmakers – MDUFA, Corza Medical, Resmed, GTCR, Zimmer Biomet, Pacira Biosciences, and Johnson & Johnson MedTech.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:08:36) - FDA releases draft MDUFA VI agreement outlining proposed legislation and program changes(00:12:50) - Resmed to sell MatrixCare software business to private equity firm for $490M/ GTCR to divest Biosurgery unit of Corza Medical(00:15:58) - Medtronic’s chief sustainability officer is departing(00:17:55) - Zimmer Biomet to pay up to $140M for Iovera nerve therapy tech from Pacira BioSciences(00:19:56) - Johnson & Johnson wins FDA approval for ThermoCool SmartTouch dual-energy ablation system -
In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi is reassured by his conversation with Joe Catanese, CEO of Calyxo, a urology startup that has developed a system designed to simplify kidney stone removal.
Catanese previously helped build Neotract, a urology startup that was acquired by Teleflex for more than $1 billion. Now, he's leading another potential gamechanger and may have his sights set on an IPO.
Speaking of gamechangers, HistoSonics continues to shatter fundraising expectations. The company recently completed a financing round that valued it at $3.75 billion. In this week's FOMO interview, HistoSonics President and CEO Mike Blue speaks with MassDevice Editor Chris Newmarker during a keynote conversation at DeviceTalks Minnesota.
In this excerpt, Blue reflects on the company's first major fundraising round, which attracted high-profile investors including Jeff Bezos and Peter Thiel, and shares his perspective on just how large the opportunity for histotripsy could become.
But first, Tom and Jim Hammerand, managing editor of Medical Design & Outsourcing, discuss AI—or LLMs, or whatever term you prefer. Is the hype beginning to fade? And what should the industry make of the recent announcement from Midjourney Medical?
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:05:29) - AI Talk with Jim Hammerand, managing editor, Medical Design & Outsourcing(00:24:46) - DeviceTalks Minnesota interview excerpt - Mike Blue, CEO and President, Histosonics(00:41:44) - Keynote Interview with Joe Catanese, CEO and President, Calyxo -
Saknas det avsnitt?
-
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi visits his MedTech happy place — renal denervation — with Recor Medical COO Helen Reeve Stoffer. Reeve Stoffer joined the company shortly before the bottom fell out of the renal denervation market in 2014. This interview picks up from that point and follows Recor's pursuit of FDA approval to where denervation technology may be applied next.
This week’s FOMO features a portion of a keynote interview with Manny Villafaña, MedTech legend and CEO of Medical 21. The conversation took place at DeviceTalks Minnesota and focuses on the dream that saved St. Jude Medical.
Skyler Rivera, associate editor of MassDevice, gives us a preview of her upcoming feature in Medical Design & Outsourcing magazine on the race to provide telesurgery capabilities to surgical robotic systems.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:02:42) - Associate Editor Skyler Rivera's path the MedTech (and MassDevice)(00:06:00) - MDO covers the race for robotic telesurgery platforms in stroke(00:11:12) - Rivera reviews the race leaders(00:16:30) - FOMO Studio - Manny Villafana, MedTech Legend and CEO of Medical 21(00:28:19) - Keynote Interview - Helen Reeve Stoffer, COO, Recor Medical -
In this episode, Host Tom Salemi is joined by Darla Hutton, Intuitive’s global vice president of cardiac surgery, to discuss the surgical robotics giant’s return to cardiac surgery.
Intuitive famously aimed for the heart at its outset but pivoted when cardiac surgery proved too complicated. Today, heart patients and surgeons are pushing for minimally invasive procedures, and Hutton, a former cardiac surgery OR nurse, has been tapped to lead the company’s push into an increasingly competitive specialty.
But first, Harmonic Drive’s Bill Frey, regional sales engineer, joins us in the FOMO Studio. Go to HarmonicDrive.net for more information.
Filling in for MassDevice’s Chris Newmarker, Senior Editor Sean Whooley wraps up the five biggest stories to come out of the American Diabetes Association meeting — Abbott, Senseonics, Sequel, Dexcom, and Insulet.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:04:43) - Abbott studies reinforce DKA opportunity following dual sensor milestone(00:07:13) - Senseonics study supports Eversense 365 CGM with automated insulin delivery tech(00:09:20) - Sequel Med Tech data supports twiist automated insulin delivery in type 2 diabetes(00:11:18) - Dexcom study highlights benefits of G7 CGM in non-insulin type 2 diabetes(00:13:01) - Insulet data backs Omnipod 6, fully closed-loop AID systems(00:16:29) - FOMO Studio - Bill Frey, regional sales engineer, Harmonic Drive(00:27:14) - Keynote Interview - Darla Hutton, Global Vice President, Cardiac Surgery Intuitive -
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Lisa Earnhardt, Executive Vice President and Group, President, Medical Devices, Abbott.
Earnhardt shared her views on Abbott’s advances in electrophysiology, pacemakers, and other technologies in this interview, which was conducted at DeviceTalks Minnesota.
In our sponsor interview ATL Medical CEO Jim Fitzgerald unpacks the meaning of its Manufacturing for Life philosophy with Managing Editor Kayleen Brown.
For more information go to www.ATLMedical.com. To find the blog mentioned in the interview, go here.
But we’ll start off with MassDevice Editor Chris Newmarker with this week’s Newsmakers – Philips, Disney, Neurovalens, Edwards, Insulet and Medtronic.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:06:00) - Philips, Disney partner to improve MRI experience for children(00:09:40) - Neurovalens earns FDA nod for neuromod for PTSD(00:12:55) - Edwards gets FDA nod for Triformis Resilia surgical tricuspid valve replacement(00:14:22) - Insulet initiates another Omnipod 5 recall affecting 7 million devices including some Dash, Eros systems(00:17:01) - Medtronic sees best revenue growth in 10 years, but overall Q4 mixed(00:21:21) - Interview with ATL Medical CEO Jim Fitzgerald(00:29:37) - Keynote Interview - Lisa D. Earnhardt, Executive Vice President and Group, President, Medical Devices, Abbott -
In this episode of OlympusTalks, host Tom Salemi is joined by Dr. Davinderbir Pannu, a gastroenterologist practicing at McLeod Health in South Carolina, and Amanda Call, Clinical Education Specialist at Olympus, for a conversation on how endoscopic imaging advancements support clinical decision-making during screening and therapeutic procedures. Together, they discuss real-world experiences using the EVIS X1™ endoscopy system and Extended Depth of Field (EDOF™) technology, with a focus on visualization, clinical efficiencies, and procedural confidence in both routine and advanced GI cases.
Chapter 1: Meet the Guests
Dr. Davinderbir Pannu discusses his career path into gastroenterology and advanced endoscopic procedures, including his current clinical practice. Amanda Call shares her background as a registered nurse and her transition into clinical endoscopy support at Olympus.Chapter 2: Clinical Challenges in GI Endoscopy
The importance of visualization in screening colonoscopy and advanced therapeutic procedures. Common challenges related to movement, anatomy, and image clarity during endoscopic exams.Chapter 3: Imaging Technologies in Practice
Overview of the EVIS X1™ endoscopy system, including TXI™ and RDI™ technologies. How EDOF technology supports visualization during procedures. Chapter 4: Supporting Screening and Therapeutic Procedures Detecting flat and serrated polyps during screening exams. Using imaging enhancements during procedures such as EMR, ESD, and third-space endoscopy. Visualization considerations in inflammatory bowel disease and other GI conditions.Chapter 5: Workflow, Ergonomics, and the Support Team
Ergonomic design considerations, including scope weight and button access. Communicating scope and equipment needs across the endoscopy team to support efficient workflows.For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts.
This podcast has been paid for by Olympus Corporation of the Americas. The views and experiences shared are those of Dr. Davinderbir Pannu, a paid consultant of Olympus Corporation and its affiliates. Olympus makes no representations regarding the accuracy or applicability of the content and disclaims all liability arising from its use. Product performance may vary, and techniques, instruments, and clinical decisions are unique to each facility and practitioner. Always refer to the Instructions for Use (IFU) and applicable labeling for guidance, risks, and cautions.ADDITIONAL RESOURCES:
Chapters(00:00:00) - Meet the Guests(00:09:03) - Clinical Challenges in GI Endoscopy(00:16:04) - Imaging Technologies in Practice(00:20:05) - Supporting Screening and Therapeutic Procedures(00:21:11) - Workflow, Ergonomics, and the Support Team
Bring more into focus. Discover EDOF technology and how it may support your clinical practice: https://info.olympusamericamarketing.com/edof-technology -
In this episode, the editorial team shares their highlights and lessons from two great days at DeviceTalks Boston.
Tom Salemi, Kayleen Brown, Chris Newmarker, Jim Hammerand, Sean Whooley and Skyler Rivera highlighted discussions on new technologies, personal stories, Boston’s ecosystem, and the power of MedTech. Joining them on the panel were special guests Saul Marquez of the Outcomes Rocket, Etienne Nichols of Greenlight Guru and Holly Scott of The Mullings Group.
3:51 – Happy Birthday Kayleen Brown!
5:13 – MassDevice Executive Editor Chris Newmarker – Power of the Personal Story
9:25 - Senior Editor Sean Whooley – Analyzing Boston’s exceptionalism
11:10 -Associate Editor Skyler Rivera – Women in MedTech breakfast
14:05 – DeviceTalks Managing Editor Kayleen Brown -Designing for Reality/ Flipping the Script
17:28 - MDO Managing Editor Jim Hammerand – News Team Assembled!
20:10 – Saul Marquez, Outcomes Rocket – Importance of Conferences
24:16 – Etienne Nichols, Greenlight Guru – Why Making a Difference Matters
28:22 – Holly Scott, Senior Partner, The Mullings Group – Serendipity and MedTech Innovators
32:10 – Tom Salem – We Must Pay it Forward, New MedTech modalities
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:03:51) - Happy Birthday Kayleen Brown(00:05:13) - – MassDevice Executive Editor Chris Newmarker – Power of the Personal Story(00:09:25) - Senior Editor Sean Whooley – Analyzing Boston’s exceptionalism(00:11:10) - Associate Editor Skyler Rivera – Women in MedTech breakfast(00:14:05) - DeviceTalks Managing Editor Kayleen Brown -Designing for Reality/ Flipping the Script(00:17:28) - MDO Managing Editor Jim Hammerand – News Team Assembled!(00:20:10) - Saul Marquez, Outcomes Rocket – Importance of Conferences/Christian Howell(00:24:16) - Etienne Nichols, Greenlight Guru – Why Making a Difference Matters(00:28:22) - Holly Scott, Senior Partner, The Mullings Group – Serendipity and MedTech Innovators(00:32:10) - Tom Salemi - Pay It Forward, New MedTech Modalities -
In this episode of DeviceTalks Weekly, Host Tom Salemi speaks with Axoft CEO and co-founder Paul Le Floch about the future of brain-computer interfaces and the material science breakthroughs powering the next generation of neural implants.
Le Floch shares how his background in materials science led to the development of “Fleuron,” Axoft’s soft, flexible implant material designed to better match the brain’s delicate tissue and reduce long-term damage caused by traditional rigid implants. The conversation explores the challenges facing the BCI industry, including device durability, signal stability, and the difficulty of commercializing implantable neurotechnology. Le Floch also discusses Axoft’s focus on treating disorders of consciousness, its collaboration with Mass General Hospital, the company’s recent $55 million Series A financing, and why Massachusetts remains both an ideal — and expensive — place to build a deep-tech MedTech startup.
In our FOMO Studio, Salemi sits down with MassMEDIC President Brian Johnson and Holly Scott of The Mullings Group to preview DeviceTalks Boston and explore the state of the Massachusetts MedTech ecosystem. Johnson reflects on MassMEDIC’s 30th anniversary, the evolution of DeviceTalks, and why Massachusetts remains one of the world’s leading hubs for medical technology innovation. The conversation covers the region’s deep strengths in robotics, orthopedics, organ transplantation, and cardiovascular technology, along with the challenges startups face in securing early-stage funding and navigating tariffs and manufacturing shifts.
And of course we start of with MassDevice Editor Chris Newmarker's top news from the pages of MassDevice - Cagent Vascular, BD, Medtronic, Johnson & Johnson MedTech, Endologix, Surmodics and Boston Scientific.
Join us May 27-28th at DeviceTalks Boston. Visit Boston.DeviceTalks.com for the full agenda and speakers.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:04:41) - Cagent Vascular reports first-in-human IVL cases, closes $41M Series D(00:06:31) - BD taps former J&J leader as new president of Interventional(00:10:09) - Endologix acquires Pounce thrombectomy system from Surmodics(00:11:32) - Medtronic to acquire peripheral nerve stim developer SPR Therapeutics(00:13:30) - Boston Scientific invests $1.5B in TAVR developer MiRus, enters $2B share repurchase agreement -
In this special episode of the DeviceTalks Women in MedTech podcast, Host Kayleen Brown brings listeners inside the 6th Women in MedTech Breakfast held May 4 at DeviceTalks Minnesota for a powerful keynote panel on “The Art of High-Stakes Decision-Making.”
The conversation features Cat Jennings, SVP and President of Vascular Therapies at Boston Scientific; Laura Stoltenberg, President and CEO of Cryosa; and Marcie DeWalt, Chief Human Resources Officer at Provation. Together, they explore what it really takes to lead through uncertainty. From billion-dollar M&A and clinical trial bets to organizational transformations and personal career pivots, the panelists share candid stories about navigating moments where the pressure is real and the outcomes are uncertain.
Throughout the discussion, the leaders examine the balance between data and intuition, the importance of stakeholder alignment, and how to develop the conviction to move forward when there is no "undo" button. Whether managing portfolio strategy at a strategic or navigating the growth of a startup, this episode offers practical frameworks for making decisions that shape companies, careers, and patient care.
Kayleen also welcomes Heather Hudnut Page and Archana Desai in-studio to discuss the inspiration behind this year’s theme and how the Women in MedTech Breakfast continues creating space for authentic leadership conversations and community-building across the industry.
Thank you to Aptyx for sponsoring the Women in MedTech Breakfast at DeviceTalks Minnesota and supporting these essential industry conversations!! Visit https://www.aptyx.com to learn more.
Join us May 27-28th at DeviceTalks Boston for the next Women in MedTech Breakfast featuring Dr. Carla Goulart Peron, Chief Medical Officer for Philips to discuss designing MedTech for reality. https://boston.devicetalks.com/
***
Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players: https://women-in-medtech.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:00:00) - Intro + DeviceTalks Boston 2026 preview(00:04:07) - In-studio guests: Heather Hudnut Page and Archana Desai(00:22:53) - Kayleen on Artemis II & High-Stakes Decision Making(00:25:40) - Keynote Panel: Cat Jennings, Laura Stoltenberg, and Marcie DeWalt(00:33:30) - M&A, Reorganizations, and Tough Business Decisions(00:50:00) - Clinical Trial Risks, Innovation Bets, and Portfolio Strategy(01:01:25) - Final Leadership Lessons: How Great Leaders Make High-Stakes Decisions(01:05:03) - Closing Remarks and Thank You to Aptyx -
In this special DeviceTalks Weekly Podcast episode, Host Tom Salemi previews the biggest conversations, technologies, and innovators heading to DeviceTalks Boston on May 27–28 at the Boston Convention & Exhibition Center.
First, Tom Salemi and Mike Moore, partner at The Mullings Group, visits with Christian Howell, CEO of Cognito Therapeutics. Howell will be speaking at DeviceTalks Boston about the neuro company’s clinical, fund-raising and partnering success.
Howell also shares insights into Cognito’s partnerships with research institutions and the future of noninvasive therapies for neurodegenerative disease. He’ll be among the many speakers address Innovation & Investment at the conference, with others including the MedTech Innovator Open Rounds sessions and venture capital investors including Abby Hunter-Syed of Olympus Innovation Ventures and Maria Berkman, MD, of Vensana Capital.
Tom and Holly Scott also speak with Dr. Sarah Matt, author of Borderless Healthcare Revolution, about the challenges of connected health adoption and why many health-tech pilots fail to scale. Matt previews her DeviceTalks Boston panel examining the “physician veto” and the barriers device makers face when introducing new digital health technologies into clinical environments.
Several sessions at DeviceTalks Boston will address the challenges and opportunities of Connected Health including a keynote interview with Ashley McEvoy, CEO of Insulet, as well as presentations by Philips, Baxter and others.
The episode also features a wide-ranging conversation with Mullings Group leaders Mike Moore and Holly Scott about the strength of the Massachusetts medtech ecosystem, the growth of surgical robotics, and the importance of conferences in building meaningful industry relationships.
If you want to join us at DeviceTalks Boston, you can register at Boston.DeviceTalks.com. Use the code DTW25 to save 25% off the price of registration.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:03:40) - Mike Moore of The Mulling Group and Tom interview Christian Howell, CEO of Cognito Therapeutics(00:15:40) - Holly Scott of the Mullings Group and Tom interview Sarah Matt, MD, author of The Borderless Healthcare Revolution(00:22:30) - Holly, Mike and Tom breakdown the components of DeviceTalks Boston and the Massachusetts MedTech industry -
In this episode of DeviceTalks Weekly, Tom Salemi talks with Wayne Allen, the co-founder and CEO of Perfuze, an Irish company developing a novel new way of blood clot aspiration. Allen and his co-founder already executed one successful exit earlier in their careers. Can they find success again with Perfuze?
This episode is sponsored by DeviceTalks Boston. Go to Boston.DeviceTalks.com to register. Use the code DTW25 to save 25%.
MassDevice Editor Chris Newmarker opens up the podcast with this week’s top stories from the pages of MassDevice – Masimo, Danaher, ResMed, Johnson & Johnson MedTech, and Medtronic.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:02:00) - Quick recap of DeviceTalks Minnesota(00:07:05) - MassDevice’s Orthopedic Device Companies Special Report for 2026(00:08:20) - Masimo shareholders give green light to $10B acquisition by Danaher(00:09:56) - ResMed enters merger agreement to acquire Noctrix Health for $340 million(00:14:03) - Johnson & Johnson says Ottava surgical robot met endpoints in pivotal bariatric surgery study(00:15:45) - Medtronic merges Cardiac Surgery, Aortic units into Cardiovascular Surgery business(00:19:45) - FOMO Studio – Yossi Bar, CEO, LEM Surgical(00:31:22) - Keynote Interview- Wayne Allen, CEO, Perfuze -
In this episode, Host Tom Salemi and Holly Scott, senior partner at The Mullings Group, preview the upcoming DeviceTalks Minnesota agenda. Join us on May 4 at the McNamara Alumni Center!
If you haven’t registered, use the code DTW25 to save 25% off the price of registration, visit https://minnesota.devicetalks.com/.
MassDevice Editor Chris Newmarker also delivers this week’s top newsmakers on the pages of MassDevice—HRS 2026, Johnson & Johnson, Stryker, Medtronic, and Teleflex.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:07:25) - The top cardiac tech stories out of HRS 2026(00:09:03) - Johnson & Johnson launches head-to-head PFA trial pitting Varipulse against Boston Scientific’s Farapulse(00:10:16) - Stryker results miss after Q1 cyberattack; company sticks with guidance(00:11:43) - Medtronic discloses cybersecurity breach in certain IT systems(00:15:30) - Teleflex picks Medtronic Coronary & Renal Denervation leader Weidman as new CEO -
In this episode of the DeviceTalks Weekly Podcast, SetPoint Medical CEO Murthy Simhambhatla gives listeners an audio glimpse of what attendees at DeviceTalks Minnesota will hear during the Bringing NeuroTechnologies to New Markets panel.
As he explains in this interview, Simhambhatla—an experienced MedTech executive—was initially skeptical of SetPoint’s potential after being invited to lead the company. But the more he read, the more he became convinced the vagal stimulator could help fight inflammation. “Cytokines don’t lie,” he said. Today, SetPoint Medical has FDA approval, is building a commercial plan, and is considering future financing, including a possible IPO.
This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.DeviceTalks.com to see the agenda. Remember to use the code DTM25 to save 25% on new registrations.
We also get a visit to our FOMO Studios from Saul Marquez, CEO of Outcome Rocket, a market research and end-to-end marketing execution agency that helps medtech and health tech organizations grow their impact and accelerate growth. See more and download the report we discuss here: https://www.outcomesrocket.com/
Finally, MassDevice Editor Chris Newmarker shares this week’s top newsmakers from MassDevice—Abbott, Johnson & Johnson MedTech, Boston Scientific, Medtronic, Pulnovo, and CathWorks.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:09:23) - 5 next-gen heart valve replacement companies you need to know(00:11:35) - Abbott completes enrollment in IVL study(00:13:50) - Johnson & Johnson MedTech to launch new AI module for EP mapping(00:15:10) - Johnson & Johnson MedTech to launch new AI module for EP mapping(00:17:12) - Medtronic leads $100M financing for artery denervation tech developer Pulnovo Medical(00:23:34) - FOMO Studio: Saul Marquez, CEO, Outcomes Rocket(00:38:19) - Keynote Conversation: SetPoint Medical CEO Murthy Simhambhatla -
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Michael Carter, SVP, President, Cranial & Spinal Technologies about the company’s deployment of robotics, AI and other tech.
Managing Editor Kayleen Brown hosts Etienne Nichols, Head of Industry Insights & Education, Greenlight Guru, on this weeks’ FOMO.
MassDevice Editor Chris Newmarker highlights the MassDevice newsmakers – Stereotaxis, Robocath, Prosomnus, Johnson & Johnson MedTech, Avanos Medical, Stryker and Amplitude Vascular Systems.
Thanks to Greenlight Guru for sitting in our FOMO studio! Download its QMSR readiness playbook, it's everything you need to get compliant with QMSR, all in one place:
https://www.greenlight.guru/qmsr-readiness-playbook-free-downloadIf you haven’t registered for DeviceTalks Minnesota or DeviceTalks Boston, use the code DTW25 to save 25%
***
Chapters(00:01:25) - Discount Code for DeviceTalks events(00:03:11) - MassDevices' Newmarker's Newsmakers(00:05:25) - Stereotaxis to acquire Robocath for up to $45M(00:09:02) - ProSomnus gets FDA nod for latest sleep apnea therapy device(00:12:08) - - Johnson & Johnson ups 2026 outlook on Q1 beats, MedTech sales rise 7.7%(00:15:11) - Avanos Medical agrees to be acquired by private equity firm in $1.3B deal(00:16:22) - Stryker makes IVL play with agreement to acquire Amplitude Vascular Systems(00:18:06) - FOMO Guest: Etienne Nichols, Head of Industry Insights & Education, Greenlight Guru(00:31:55) - Keynote Interview- Michael Carter, SVP President, Cranial & Spinal Technologies, Medtronic
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe -
In this episode of the DeviceTalks Women in MedTech podcast, Host Kayleen Brown sits down with Gaele Lalahy, Chief Operating Officer at Plexāā, to discuss what it looks like to treat patients as true co-designers, not only in product development but across the entire pre-surgery experience.
Lalahy shares the clinical foundation behind BLOOM⁴³, Plexāā’s wearable, at-home device used the night before breast surgery to increase blood flow and support healing through supraphysiological preconditioning, and explains how Plexāā pairs the device with a holistic app that helps patients feel prepared, informed, and supported before and after surgery.
Kayleen also welcomes Tom Salemi, Editorial Director of DeviceTalks, for an in-studio conversation that connects the episode’s theme to the broader MedTech ecosystem, including a look ahead at DeviceTalks Minnesota, May 4 and DeviceTalks Boston, May 27–28. Together, they discuss how listening to the end user shapes better outcomes, better experiences, and better leadership.
* Mentioned in the interview * Check out this DeviceTalks Weekly episode featuring Samay's CEO Maria Artunduaga: https://www.devicetalks.com/how-samays-ceo-came-up-with-the-sound-idea-for-a-device-to-battle-copd-win-medtech-innovator/
***
Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players: https://women-in-medtech.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:00:08) - Intro to theme: patient as co‑designer(00:03:38) - Interview with In-Studio guest, Tom Salemi(00:04:29) - DeviceTalks Minnesota (May 4) & DeviceTalks Boston (May 27–28) preview(00:14:17) - Keynote interview with Gaele Lalahy, COO, Plexāā(00:15:59) - Gaele’s origin story: gymnast mindset, Panasonic, and “unlearning” into MedTech(00:26:50) - Plexāā + BLOOM⁴³ explained: reducing complications with supraphysiological preconditioning(00:39:55) - Leadership + allyship: building teams, saying yes, and mentor shout-outs -
In this episode of the DeviceTalks Weekly Podcast, OrthAlign CEO Eric Timko explains how he’s built two successful companies in the wake of surgical robotics’ rise in orthopedics. He also shares sage advice from his father—words that ultimately led him to a career in medical devices.
This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off registration.
In this week’s Newmarker’s Newsmakers, Host Tom Salemi shares his experience from MedTech Innovator’s Radar Forum. Then he and Chris Newmarker review the biggest news on MassDevice: Stryker, Johnson & Johnson MedTech, Intuitive, Baxter, and the Transcatheter Heart Valves Special Report.***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:02:30) - MedTech Innovator Radar Forum(00:09:30) - MassDevice’s Transcatheter Heart Valves Special Report(00:11:08) - Stryker operations fully restored after cyberattack(00:14:55) - Johnson & Johnson brings next-gen Varipulse PFA catheter to Europe(00:16:30) - Former Intuitive EVP Brian Miller joins Sovato as CEO(00:21:18) - Former Baxter CEO takes the corner office at Hologic as go-private deal closes(00:26:20) - Keynote interview: Eric Timko, CEO, OrthAlign -
In this episode of the DeviceTalks Weekly podcast, Amaza Reitmeier shares with Host Tom Salemi why she left the company she never thought she’d leave — Medtronic — to lead Pharaoh Neuro, a company developing a novel approach to treating stroke patients by removing harmful blood from cerebrospinal fluid. Reitmeier shares lessons from her own career and her mentors on timing big moves, learning what you don’t know, and why some of MedTech’s biggest opportunities remain hidden in plain sight.
This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off the registration fee.
Salemi and MassDevice Editor Chris Newmarker offer encouragement to exercising listeners while delivering this week’s Newmarker’s Newsmakers — including updates on cardiology companies, HistoSonics, Boston Scientific, Johnson & Johnson MedTech, Abbott, the Mayo Clinic, and WHOOP.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:08:12) - The biggest cardiology tech stories out of ACC 2026(00:11:45) - HistoSonics kicks off study using Edison histotripsy system in BPH(00:14:20) - Boston Scientific completes Valencia Technologies acquisition(00:16:00) - Johnson & Johnson MedTech shares findings for Impella CP in left ventricle support(00:16:27) - Abbott joins $575M funding round for wearable maker WHOOP(00:22:20) - Keynote Interview, Amaza Reitmeier, CEO, Pharaoh Neuro -
In the final episode of AbbottTalks season 3, hosts Tom Salemi and Kayleen Brown sit down with Rebecca Wilkins, divisional vice president of R&D for Abbott’s Neuromodulation business, to discuss the technologies Abbott is advancing for chronic pain and movement disorders.
Wilkins explains how Abbott’s spinal cord stimulation platforms, Proclaim™ DRG Neurostimulation System, and Infinity™ deep brain stimulation system are designed to interrupt errant nervous system signals, helping patients manage conditions ranging from chronic pain and Parkinson’s disease to, potentially, treatment-resistant depression.
The conversation also highlights the features shaping Abbott’s neuromodulation portfolio, including Bluetooth-enabled connectivity, the NeuroSphere™ Virtual Clinic for remote programming, improved MRI compatibility including prone MRI access, and device options that balance small size with low recharge demands.
Wilkins also shares new data presented at NANS showing significant reductions in pain-related healthcare encounters for patients using Abbott’s spinal cord stimulation and DRG therapies.This episode is brought to you by Confluent Medical Technologies. To learn more about Confluent, visit: https://confluentmedical.com/. Make sure to catch Confluent's March DeviceTalks Tuesdays webinar highlighting its new technology, Filmcast Select™: https://event.on24.com/wcc/r/5241831/7E70E13249532E05CA8FB3D51421AD71?partnerref=confluent
***
Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/ Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:00:00) - Intro: Reflecting on Season 3(00:05:22) - (Part 1) Interview with Confluent Medical's Brittany Mai(00:07:56) - Keynote Interview: Rebecca Wilkins, DVP of R&D at Abbott’s neuromodulation business(00:13:57) - A Personal Connection: How DBS Impacted a Family(00:16:21) - Innovation in Connectivity: Bluetooth and NeuroSphere™ Virtual Clinic(00:21:37) - (Part 2) Interview with Confluent Medical's Brittany Mai(00:24:42) - Targeted Therapy: Understanding Spinal Cord and DRG Stimulation(00:32:37) - Breaking Barriers: MRI Compatibility and Device Longevity(00:36:04) - New Data from NANS: Validating Patient Outcomes -
In this episode of DeviceTalks Weekly, Medtronic’s Blake Tatum, Vice President of U.S. Commercial for Acute Care & Monitoring, joins Host Tom Salemi to unpack the evolving patient monitoring landscape. Tatum shares how Medtronic is integrating sensors, data, and digital health to support clinicians from the ICU to the home, why partnerships are reshaping the competitive playbook, and how lessons from the pandemic are driving a new focus on accuracy, equity, and connectivity in care delivery.
This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.Devicetalks.com to check out the amazing agenda!
Then Salemi and MassDevice editor Chris Newmarker review this week’s MedTech newsmakers including surgical robotics, Abbott, Stryker, Boston Scientific, and Medtronic.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:05:15) - 10 surgical robotics companies you need to know (Go to MassDevice.com to download the report)(00:08:09) - Abbott completes Exact Sciences acquisition(00:09:37) - Stryker reportedly brings most services affected by cyberattack back online(00:11:20) - Boston Scientific has reportedly had pacemaker battery problems for years(00:14:01) - Round up of Medtronic News(00:21:30) - Keynote interview with Medtronic’s Blake Tatum -
In this episode of DeviceTalks Weekly, Distalmotion CEO Greg Roche updates Host Tom Salemi on the surgical robotics company’s commercial roll out of Dexter, a robotic system designed for ambulatory surgery centers. Roche shares the lessons he’s learned after a decade in surgical robotics and why he’s particularly optimistic about his company’s outcome.
You can hear Greg Roche’s first appearance on the podcast right here: https://www.devicetalks.com/why-distalmotions-roche-sees-dexters-small-size-as-big-advantage-in-the-robotics-surgical-market/
This episode is sponsored by DeviceTalks Boston. Register at Boston.DeviceTalks.com. Use the code DTW25 to save 25% off the registration price.
Rachel Robinson, COO of MassMEDIC, joins the MassDevice Newmarker’s Newsmakers with Salemi and Editor Chris Newmarker – Stryker, CMR Surgical, Revolve Surgical, JenaValve, and MassDevice’s Surgical Robotics Special Report for 2026. You can download the report with 70+ profiles of surgical robotics companies here - https://www.massdevice.com/surgical-robotics-special-report-2026/
Robinson also welcomes listeners to attend MassMEDIC’s Symposium & Gala on April 2. Go to MassMEDIC.com to see the agenda and to register.
***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Chapters(00:04:15) - MassMEDIC COO Rachel Robinson discusses the Medtech Impact Symposium & Gala(00:10:05) - MassDevice’s Surgical Robotics Special Report for 2026(00:11:58) - Stryker CEO Kevin Lobo joins GE HealthCare board of directors(00:14:35) - CMR Surgical, Nvidia collab to train next-gen surgical robots(00:18:02) - Revolve Surgical wins FDA clearance for surgical robot(00:21:00) - JenaValve wins FDA nod for Trilogy heart valve system(00:25:45) - Keynote Interview – Greg Roche, CEO, Distalmotion - Visa fler
